Last reviewed · How we verify
Placebo Matched to MTX — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo Matched to MTX (Placebo Matched to MTX) — Hoffmann-La Roche. This drug is a placebo, meaning it has no active therapeutic effect.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo Matched to MTX TARGET | Placebo Matched to MTX | Hoffmann-La Roche | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo Matched to MTX CI watch — RSS
- Placebo Matched to MTX CI watch — Atom
- Placebo Matched to MTX CI watch — JSON
- Placebo Matched to MTX alone — RSS
Cite this brief
Drug Landscape (2026). Placebo Matched to MTX — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-matched-to-mtx. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab